| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/10/1990 | EP0349949A2 Benzodiazepine derivatives |
| 01/10/1990 | EP0349654A1 Agent for prophylaxis and treatment of pancreatic disease or the like |
| 01/10/1990 | EP0349570A1 Renin inhibitors containing a cyclopropyl amino acid and/or a cycloalkyl transition-state analogue |
| 01/10/1990 | EP0349545A1 New cardiodilatin fragment, process for preparing same and use thereof. |
| 01/10/1990 | EP0210332B1 Process for the purification of plasminogen activators |
| 01/10/1990 | EP0122936B1 Lymphocyte growth factor |
| 01/10/1990 | CN1038649A Extraction and purification of an anticoagulant principle from the south american leech haementeria ghilanii |
| 01/09/1990 | US4892939 Oligopeptidyl-5-fluorouridine compounds and process for preparing the same |
| 01/09/1990 | US4892828 Monoclonal antibody for human hematopoietic glycoproteins and method |
| 01/09/1990 | US4892827 Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects |
| 01/09/1990 | US4892743 Novel hybrid interferon species |
| 01/09/1990 | US4892089 Enzyme, acoustic impulses |
| 01/09/1990 | CA1264294A1 METHOD FOR PRODUCING HUMAN LEUKOCYTE INTERFERON .alpha.-2 |
| 01/08/1990 | EP0315627A4 A method to treat blood. |
| 01/08/1990 | EP0289584A4 Wound healing and bone regeneration. |
| 01/03/1990 | EP0349480A1 Supression of cell proliferation by decorin |
| 01/03/1990 | EP0349451A1 Peptide molecules active against Gram-positive germs |
| 01/03/1990 | EP0349354A1 Peptides PF10 to PF19 from a retro virus HIV, method for the synthesis of these peptides and their use, particularly in diagnostics |
| 01/03/1990 | EP0349342A2 Polypeptides with cell-spreading activity |
| 01/03/1990 | EP0349071A1 Coccidiosis vaccine |
| 01/03/1990 | EP0349048A2 Osteogenic growth factors derived from regenerating bone marrow |
| 01/03/1990 | EP0348967A2 Synthetic lung surfactant preparation comprising lipids and polypeptides |
| 01/03/1990 | EP0348892A2 Sialic acid-bonded octapeptide and preparation thereof |
| 01/03/1990 | EP0348819A2 Anorexigenic and hypotensive peptides |
| 01/03/1990 | EP0348725A2 Species-specific epitode of chlamydia trachomatis and antibodies that recognize the same |
| 01/03/1990 | EP0348517A1 Kidney growth accelerator |
| 01/03/1990 | EP0348399A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes. |
| 01/03/1990 | EP0211835B1 Pharmaceutical compositions of microbially produced interleukin-2 |
| 01/02/1990 | US4891359 Hemostatic collagen paste composition |
| 01/02/1990 | US4891358 Atrial natriuretic factor |
| 01/02/1990 | US4891357 Methods and compositions for stimulation of appetite |
| 01/02/1990 | US4891356 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 01/02/1990 | US4891319 Protection of proteins and the like |
| 01/02/1990 | US4891226 Pharmaceutical which can be administered nasally, a process for its preparation, and its use |
| 01/02/1990 | US4891221 Whole blood antiviral process and composition |
| 01/02/1990 | US4891208 Steroidal liposomes |
| 12/28/1989 | WO1989012690A1 Method for the production of monoclonal antibodies utilizing a germfree animal |
| 12/28/1989 | WO1989012687A1 Retinoic acid receptor |
| 12/28/1989 | WO1989012683A1 Nucleic acid encoding the p30 protein of toxoplasma gondii |
| 12/28/1989 | WO1989012681A1 Tissue plasminogen activator analogues having improved activity |
| 12/28/1989 | WO1989012680A1 USE OF MODIFIED tPA TO DETECT BLOOD CLOTS |
| 12/28/1989 | WO1989012677A1 Superoxide dismutase analogs having novel binding properties |
| 12/28/1989 | WO1989012647A1 Insulin precursors |
| 12/28/1989 | WO1989012646A1 Crf analogs |
| 12/28/1989 | WO1989012645A1 Angiogenic potentiating peptides which potentiate angiogenic factors |
| 12/28/1989 | WO1989012644A1 Endotoxin binding protein and uses thereof |
| 12/28/1989 | WO1989012641A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012464A1 Controlled release systems containing heparin and growth factors |
| 12/28/1989 | WO1989012463A1 Method and therapeutic compositions for the treatment of myocardial infarction |
| 12/28/1989 | WO1989012462A1 Enterically transmitted non-a/non-b hepatitis viral agent |
| 12/28/1989 | WO1989012461A1 Antagonists of viral transactivating proteins |
| 12/28/1989 | WO1989012458A1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 12/28/1989 | WO1989012457A1 Human myeloperoxydasis and its therapeutic application |
| 12/28/1989 | WO1989012456A1 Method of purifying cross-linked hemoglobin |
| 12/28/1989 | WO1989012441A1 Cosmetic and skin treatment compositions |
| 12/28/1989 | WO1989012399A1 Nisin compositions for use as enhanced, broad range bactericides |
| 12/28/1989 | WO1989011277A3 Porphyrin and phthalocyanine antiviral compositions |
| 12/28/1989 | DE3919852A1 Mini-proinsulin, its preparation and use |
| 12/27/1989 | EP0348208A2 Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
| 12/27/1989 | EP0348086A2 Novel peptides, their use as immuno suppressants and processes for their preparation |
| 12/27/1989 | EP0347987A2 Tripeptide renin inhibitors with N-terminal carbamoyl or acyl groups |
| 12/27/1989 | EP0347959A1 Antibodies against fibrin, immunogen used in their preparation, process for determining fibrin and pharmaceutical preparation based on the antibodies |
| 12/27/1989 | EP0347931A2 Polypeptide comprising repeated cell-adhesive core sequences |
| 12/27/1989 | EP0347915A2 Method and agents for inhibiting low density lipoprotein synthesis |
| 12/27/1989 | EP0347890A1 Amino acid nutrient compositions |
| 12/27/1989 | EP0347845A2 Insulin precursors, their preparation, and DNA sequences, expression vehicles and primers and a process for producing human insulin and analogues |
| 12/27/1989 | EP0347820A1 Novel spergualin-related compounds and preparation and application of the same |
| 12/27/1989 | EP0347802A2 Neurokinin A antagonists |
| 12/27/1989 | EP0347781A2 Mini-proinsulin, its oroduction and use |
| 12/27/1989 | EP0347714A2 Dialysing and rinsing solution for intraperitoneal dispensing |
| 12/27/1989 | EP0347436A1 Bradykinin antagonist peptides |
| 12/27/1989 | EP0347435A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 12/27/1989 | EP0175764B1 Method and agents for measuring protein aging |
| 12/27/1989 | CN1038306A Recombinant retroviruses |
| 12/27/1989 | CN1038283A Amino acid ester pharmaceuticals containg same and use thereof |
| 12/27/1989 | CN1006197B Injectable sustained release formulation |
| 12/27/1989 | CA1264032A1 Biologic and method of preparing same |
| 12/27/1989 | CA1264030A1 Protein absorption enhancing agents |
| 12/26/1989 | US4889919 Biologically active PDGF derived A-chain homodimers |
| 12/26/1989 | US4889917 Peptide |
| 12/26/1989 | US4889842 Concanavalin A dimers as therapeutic agents |
| 12/26/1989 | US4889808 Method of enchancing t-PA and SCU-PA production |
| 12/26/1989 | US4889803 Production of interferon gamma |
| 12/26/1989 | US4889722 Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| 12/20/1989 | EP0347376A2 Novel polypeptides with an anticoagulant activity |
| 12/20/1989 | EP0347365A2 HIV-2 virus variants |
| 12/20/1989 | EP0347230A2 Miniclones |
| 12/20/1989 | EP0347143A2 Nlteration of the interaction of a T-cell receptor with a protein-tyrosine kinase |
| 12/20/1989 | EP0347105A2 S-sulfonated calcitonin derivatives |
| 12/20/1989 | EP0347078A1 Hybrid proteins |
| 12/20/1989 | EP0347057A1 Method of treating myeloid leukemias |
| 12/20/1989 | EP0347041A2 Compositions and method for treating or preventing infections in animals |
| 12/20/1989 | EP0346894A2 Extraction and purification of an anticoagulant substance from the south american leech, haementeria ghilianii |
| 12/20/1989 | EP0346847A2 Amino acid derivatives |
| 12/20/1989 | EP0346798A1 Use of a cholinergic agonist and growth hormone releasing hormone for preparing pharmaceutical compositions useful in the differential diagnosis of somatotropic deficiency |
| 12/20/1989 | EP0346741A2 Fibrin(ogen) derivatives, process for preparing them and their use |
| 12/20/1989 | EP0346710A2 cDNAs coding for members of the carcinoembryonic antigen family |
| 12/20/1989 | EP0346501A1 Pharmaceutical preparation for treating immunodeficiency conditions |
| 12/20/1989 | EP0346500A1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 12/20/1989 | EP0346413A1 Potentiation of erythropoiesis |